A warning has been issued over drinking habits that could actually accelerate Alzheimer’s disease. New research published in ...

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...

Analysis of human brain tissue revealed differences in how immune cells behave in brains with Alzheimer's disease compared to ...

A recent study found that relatively healthy obesity may reduce the risk of developing Alzheimer's disease.

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

Researchers discovered that the enzyme TYK2 alters the tau protein, promoting its accumulation in the brain, a process linked ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Officials said over 71,000 Oklahomans are currently living with Alzheimer's disease. Nationally, that number is approaching 7 ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...